{"id":"W4391921558","doi":"10.1186/s43556-023-00167-7","title":"Annexin A5-DM1 protein-drug conjugate for the treatment of triple-negative breast cancer","year":2024,"lang":"en","type":"letter","venue":"Molecular Biomedicine","topic":"S100 Proteins and Annexins","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"ca_institutions":"AbCellera (Canada)","funders":"Oklahoma Center for the Advancement of Science and Technology","keywords":"Triple-negative breast cancer; Conjugate; Drug; Breast cancer; Medicine; Triple negative; Cancer; Oncology; Internal medicine; Cancer research; Pharmacology; Mathematics","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001742786,0.000606658,0.0006300298,0.0001643271,0.000101431,0.00003409436,0.0004160996,0.000543229,0.00008458676],"category_scores_gemma":[0.00003312062,0.0003657196,0.0005331527,0.0002641156,0.0004712754,0.000002592746,0.00008051303,0.0003069995,0.00001020351],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007743882,"about_ca_system_score_gemma":0.0002792477,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006395129,"about_ca_topic_score_gemma":0.00005294145,"domain_scores_codex":[0.9977124,0.00009069373,0.0005024207,0.0008178321,0.0003549374,0.0005217575],"domain_scores_gemma":[0.9985318,0.00003572831,0.0002801523,0.000810703,0.0002578317,0.00008382124],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003205146,0.0001351479,0.000004750327,0.0004807406,0.001479514,0.000178845,0.0001363152,0.000004182964,0.3593303,0.00002128012,0.6304328,0.007475602],"study_design_scores_gemma":[0.001603304,0.001281942,0.00001367308,0.0002908607,0.0004214044,0.00002990415,0.00004456682,0.00005050699,0.2823209,0.000141931,0.7134784,0.0003225466],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"commentary","genre_scores_codex":[0.01891207,0.05487484,0.002609971,0.9055437,0.002025943,0.0080191,0.007620763,0.00006568918,0.0003278496],"genre_scores_gemma":[0.1513814,0.01312028,0.002075121,0.6231354,0.04217746,0.01845963,0.0137225,0.001397443,0.1345308],"genre_candidate":"commentary","genre_consensus":"commentary","teacher_disagreement_score":0.2824084,"threshold_uncertainty_score":0.9998795,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01055322569096265,"score_gpt":0.2734772695427223,"score_spread":0.2629240438517596,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}